Cargando…

A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

BACKGROUND: Intermediate-stage hepatocellular carcinoma (HCC), defined according to the Barcelona Clinic Liver Cancer (BCLC) staging system, is a heterogeneous condition with variable clinical benefits from transarterial chemoembolization (TACE). This study aimed to develop a simple validated progno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogasawara, Sadahisa, Chiba, Tetsuhiro, Ooka, Yoshihiko, Kanogawa, Naoya, Motoyama, Tenyu, Suzuki, Eiichiro, Tawada, Akinobu, Azemoto, Ryosaku, Shinozaki, Masami, Yoshikawa, Masaharu, Yokosuka, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412579/ https://www.ncbi.nlm.nih.gov/pubmed/25919025 http://dx.doi.org/10.1371/journal.pone.0125244

Ejemplares similares

Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia
por: Ooka, Yoshihiko, et al.
Publicado: (2014)

Successful Interventional Treatment for Arterioportal Fistula Caused by Radiofrequency Ablation for Hepatocellular Carcinoma
por: Kanogawa, Naoya, et al.
Publicado: (2014)

Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma
por: Suzuki, Eiichiro, et al.
Publicado: (2014)

Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma
por: Saito, Tomoko, et al.
Publicado: (2014)

Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma
por: Ogasawara, Sadahisa, et al.
Publicado: (2016)

Fatal Diaphragmatic Hernia following Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report and Literature Review
por: Saito, Tomoko, et al.
Publicado: (2015)

Intracranial Metastasis in a Patient with Hepatocellular Carcinoma and Gastric Cancer
por: Tawada, Akinobu, et al.
Publicado: (2014)

Impact of Radiofrequency Ablation-Induced Glisson’s Capsule-Associated Complications in Patients with Hepatocellular Carcinoma
por: Wakamatsu, Toru, et al.
Publicado: (2017)

Successful Resection of Intracranial Metastasis of Hepatocellular Carcinoma
por: Okimoto, Kenichiro, et al.
Publicado: (2013)

Simultaneous Resection of Disseminated Hepatocellular Carcinoma and Colon Cancer
por: Haga, Yuki, et al.
Publicado: (2013)

Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma
por: Ogasawara, Sadahisa, et al.
Publicado: (2016)

Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma
por: Ishikawa, Kentaro, et al.
Publicado: (2018)

Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
por: Saito, Tomoko, et al.
Publicado: (2013)

Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners
por: Chiba, Tetsuhiro, et al.
Publicado: (2014)

Switching to systemic therapy after locoregional treatment failure: Definition and best timing
por: Ogasawara, Sadahisa, et al.
Publicado: (2020)

Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance
por: Maruyama, Hitoshi, et al.
Publicado: (2018)

Successful Treatment of Hepatocellular Carcinoma Complicated by Fanconi Anemia
por: Takahashi, Koji, et al.
Publicado: (2017)

Henoch-Schönlein Purpura Complicated by Hepatocellular Carcinoma
por: Akizue, Naoki, et al.
Publicado: (2017)

Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma
por: Kanogawa, Naoya, et al.
Publicado: (2020)

Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors
por: Kanda, Tatsuo, et al.
Publicado: (2017)

How we use hepatic arterial infusion chemotherapy in the new era of systemic therapy?
por: Ogasawara, Sadahisa, et al.
Publicado: (2022)

Incidence and hemodynamic feature of risky esophageal varices with lower hepatic venous pressure gradient
por: Maruyama, Hitoshi, et al.
Publicado: (2019)

Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study
por: Sato, Tsunenobu, et al.
Publicado: (2015)

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma
por: Yokoyama, Masayuki, et al.
Publicado: (2017)

Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study
por: Miksad, Rebecca A., et al.
Publicado: (2019)

Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma
por: Kondo, Takayuki, et al.
Publicado: (2022)

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
por: Kanzaki, Hiroaki, et al.
Publicado: (2021)

Compensating effect of minor portal hypertension on the muscle mass loss-related poor prognosis in cirrhosis
por: Maruyama, Hitoshi, et al.
Publicado: (2017)

The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma
por: Kondo, Takayuki, et al.
Publicado: (2022)

Genome-Wide Mapping of Bivalent Histone Modifications in Hepatic Stem/Progenitor Cells
por: Kanayama, Kengo, et al.
Publicado: (2019)

Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
por: Mukai, Shohei, et al.
Publicado: (2021)

Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
por: Kudo, Masatoshi, et al.
Publicado: (2022)

Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment
por: Llovet, Josep M., et al.
Publicado: (2022)

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Ao, Junjie, et al.
Publicado: (2021)

Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015)

Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma
por: Chen, Lei, et al.
Publicado: (2020)

Clinical outcomes of endoscopic ultrasound-guided ethanol injection for hepatocellular carcinoma in the caudate lobe
por: Nakaji, So, et al.
Publicado: (2016)

Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ep4s6e1rbc5bscks45h0m6dnvq